Invention Grant
- Patent Title: MonoMac-1 cells expressing CD16 and CD163
-
Application No.: US16334808Application Date: 2017-09-20
-
Publication No.: US11846629B2Publication Date: 2023-12-19
- Inventor: Jay Rappaport , Sarah Vakili
- Applicant: Temple University—Of The Commonwealth System of Higher Education
- Applicant Address: US PA Philadelphia
- Assignee: Tulane University
- Current Assignee: Tulane University
- Current Assignee Address: US LA New Orleans
- Agency: Riverside Law LLP
- International Application: PCT/US2017/052399 2017.09.20
- International Announcement: WO2018/057559A 2018.03.29
- Date entered country: 2019-03-20
- Main IPC: C07K14/705
- IPC: C07K14/705 ; C07K14/73 ; C07K14/735 ; C12N5/0786 ; G01N33/50
Abstract:
The invention provides monocytes expressing CD16 and CD163 and experimental system for drug screening or evaluating drug candidates where the modulation of CD16 and CD163 is desired.
Public/Granted literature
- US20200018745A1 MonoMac-1 Cells Expressing CD16 and CD163 Public/Granted day:2020-01-16
Information query
